🔬DeepMind Co-Scientist Earns 2 Nature Papers, Drug Hits
TL;DR
Google DeepMind published two Nature papers on Co-Scientist, a multi-agent system that generates and ranks research hypotheses. Stanford researchers used it to flag Vorinostat, an approved cancer drug, as a liver-fibrosis candidate, and it now rolls out via Gemini for Science.
Google DeepMind published two Nature papers on Co-Scientist, a multi-agent system that generates and ranks research hypotheses. Stanford researchers used it to flag Vorinostat, an approved cancer drug, as a liver-fibrosis candidate, and it now rolls out via Gemini for Science.
Key Points
Two Nature papers published May 19, 2026 (Co-Scientist and ERA)
Multi-agent setup generates, debates, ranks, and evolves hypotheses
Stanford team identified Vorinostat as a liver-fibrosis candidate
Rolling out to working researchers through Gemini for Science
Why It Matters
Peer review moves 'AI for science' from demo to method, and a named drug candidate is something a wet lab can actually test next.
Quick Facts
Frequently Asked Questions
Why does this matter?
Peer review moves 'AI for science' from demo to method, and a named drug candidate is something a wet lab can actually test next.
What happened?
Google DeepMind published two Nature papers on Co-Scientist, a multi-agent system that generates and ranks research hypotheses. Stanford researchers used it to flag Vorinostat, an approved cancer drug, as a liver-fibrosis candidate, and it now rolls out via Gemini for Science.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,337 builders reading daily.